Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06151600 · ClinicalTrials.gov registry record
A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J
A clinical trial of Peripheral Neuropathy and Neuromuscular Diseases, sponsored by Elpida Therapeutics SPC.
- Recruiting
- Registry status
- 20
- Enrollment target
- 3
- Study locations
NCT06151600 is a study of Peripheral Neuropathy and Neuromuscular Diseases that is actively recruiting participants, run by Elpida Therapeutics SPC. The registered enrollment target is 20 participants, below the 79-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (75% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06151600, a study of Peripheral Neuropathy and Neuromuscular Diseases, is actively recruiting participants, sponsored by Elpida Therapeutics SPC.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a multicenter, longitudinal, prospective observational natural history study of subjects with a molecularly confirmed diagnosis of CMT4J. The study will enroll 20 subjects of any age into a uniform protocol for follow-up and evaluations. Subject visits will occur every 12 months + 4 weeks for up to 2 years.
Conditions Studied
Study Locations (3)
California
- Stanford University - San Francisco
Iowa
- University of Iowa - Iowa City
Texas
- University of Texas Southwestern - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-07-29 |
| Est. Completion | 2032-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06151600
The ClinicalTrials.gov registry entry for NCT06151600 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 79-participant average among 27 other Peripheral Neuropathy trials with a reported enrollment target (75% lower). The listed sponsor is Elpida Therapeutics SPC, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Peripheral Neuropathy appearing as the primary indexed condition, and to 0 interventions.
NCT06151600 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Iowa, Texas.
Frequently Asked Questions
What is clinical trial NCT06151600 about?
NCT06151600 is a clinical study titled "A Prospective Natural History and Outcome Measure Discovery Study of Charcot-Marie-Tooth Disease, Type 4J". This is a multicenter, longitudinal, prospective observational natural history study of subjects with a molecularly confirmed diagnosis of CMT4J. The study will enroll 20 subjects of any age into a uniform protocol for follow-up and evaluations. Subject visits will occur every 12 months + 4 weeks fo...
What is the current status of trial NCT06151600?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-07-29. Estimated completion is 2032-03-01.
What conditions does trial NCT06151600 study?
This clinical trial studies the following conditions: Peripheral Neuropathy, Neuromuscular Diseases, Neuro-Degenerative Disease.
Who is sponsoring clinical trial NCT06151600?
This trial is sponsored by Elpida Therapeutics SPC, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06151600 being conducted?
This trial has 3 study locations across California, Iowa, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Neuropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Causative Role for Amylin in Diabetic Peripheral Neuropathy
RECRUITING
-
Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
DoD AtMS for Posttraumatic Peripheral Neuropathic Pain
RECRUITING · NA
-
Intermittent Dosing of Dorsal Root Ganglion Stimulation as an Alternate Paradigm to Continuous Low-Frequency Therapy
RECRUITING · NA
-
Investigational Use of Neuromuscular Ultrasound
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.